AnanthJ.V., BanT.A., LehmannH.E., BennettJ.: Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenia.Can. Psychiatr. Assoc. J.15: 15–20, 1970.
2.
BidderT.G., MandelL.R., AhnH.S., Vanden HeuvelW.J.A., WalkerR.W.: Blood and urinary dimethyltryptamine in acute psychotic disorders.Lancet1: 165, 1974.
3.
BleulerE.: Dementia praecox, or the group of schizophrenia.New York, International University Press,1966.
4.
BruneG.G., HimwichH.E.: Effects of methionine loading on the behavior of schizophrenic patients.J. Nerv. Ment. Dis.134: 447–450, 1962.
5.
CarpenterW.T.Jr., FinkE.B., NarasimhachariN., HimwichH.E.: A test of the transmethylation hypothesis in acute schizophrenic patients.Am. J. Psychiatry132: 1067–1071, 1975.
6.
FaubryeA., PindK.: Occurrence of bufotenin in the urine of schizophrenic patients and normal persons.Nature220: 489, 1968.
7.
FischerE., SpatzH.: Studies on urinary elimination of bufotenin-like substances in schizophrenia.Biol. Psychiatry2: 235–240, 1970.
8.
FolinO.: The preparation of sodium tungstate-free from molybdate, together with a simplified process for the preparation of a correct uric acid reagent (and some comments).J. Biol. Chem.106: 311–314, 1934.
9.
FranzenF., GrossH.: Tryptamine, N,N-dimethyl-5-hydroxytryptamine, and 5-methoxytryptamine in human blood and urine.Nature206: 1052, 1965.
10.
FriedmanE., ShopsinB., SathananthanG., GershonS.: Blood platelet monoamine oxidase activity in psychiatric patients.Am. J. Psychiatry131: 1392–1394, 1974.
11.
GillinJ.C., KaplanJ., StillmanR., WyattR.J.: The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.Am. J. Psychiatry133: 203–208, 1976.
12.
GrossH., FranzenF.: Zur Bestimmung körpereigener Amine in biologischen Substraten.Biochem. Z.340: 403–412, 1964.
13.
HimwichH.E. Ed. Biochemistry, Schizophrenias and Affective Illnesses.Baltimore, Williams and Wilkins Co.,79–122, 1970.
14.
JacobsS.L., SobelS., HenryR.J.: Specificity of the trihydroxyindol method for the determination of urinary catecholamines.J. Clin. Endocrinol Metab.21: 305–314, 1961.
Lovett DoustJ.W., HuszkaL.: Amines and aphrodisiacs in chronic schizophrenia.J. Nerv. Ment. Dis.155: 261–264, 1972.
17.
MalamudW., HoaglandH., KaufmanI.C.: A new psychiatric rating scale.Psychosom. Med.8: 243–245, 1946.
18.
MalamudW., SandsS.L.: A revision of the psychiatric rating scale.Am. J. Psychiatry104: 231–237, 1947.
19.
MandellA.J., BuckinghamB., SegalD.: Behavioral, metabolic and enzymatic studies of a brain indolethylamine N-methylating system, In: Brain Chemistry and Mental Disease.HoB.T., McIsaacW.M. Eds., New York, Plenum Press,37, 1971.
20.
MandelL.R., AhnH.S., Vanden HeuvelW.J.A., WalkerR.W.: Indoleamine-N-methyltransferase in human lung.Biochem. Pharmacol.21: 1197–1200, 1972.
21.
MurphyD., WyattR.: Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.Nature238: 225–226, 1972.
22.
NarasimhachariN., HellerB., SpaideJ., HaskovecL., FujimoriM., TabushiK., HimwichH.E.: Urinary studies of schizophrenics and controls.Biol. Psychiatry3: 9–20, 1971a.
NarasimhachariN., PlautJ.M., LeinerK.Y.: Thin-layer and gas-liquid chromatographic methods for the identification and estimation of indole amines in urine samples.Biochem. Med.5: 304–310, 1971c.
25.
NarasimhachariN., SpaideJ., HellerB.: Gas liquid Chromatographie and mass spectrometric studies on trymethylsilyl derivatives of N-methyl and N,N-dimethyltryptamines.J. Chromatogr. Sci.9: 502–505, 1971d.
26.
NarasimhachariN., HimwichH.E.: The determination of bufotenin in urine of schizophrenic patients and normal controls.J. Psychiatr. Res.9: 113–121, 1972.
27.
NarasimhachariN., HimwichH.E.: GC-MS identification of bufotenin in urine samples from patients with schizophrenia or infantile autism.Life Sci.12: 475–478, 1973.
OsmondH., SmythiesJ.R. (citing Harley-Mason J.): Schizophrenia: a new approach.J. Ment. Sci.98: 309–315, 1952.
30.
PisanoJ.J., CroutJ.R., AbrahamD.: Determination of 3-methoxy-4-hydroxymandelic acid in urine.Clin. Chim. Acta7: 285–291, 1962.
31.
PollinW., CardonP.V., KetyS.S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid.Science133: 104–105, 1961.
32.
SaavedraJ.M., AxelrodJ.: Psychotomimetic N-methylated tryptamines: formation in brain in vivo andin vitro. Science175: 1365–1366, 1972.
33.
SjoerdsmaA., OatesJ.A., ZaltmanP., UnderfriendS.: Identification and assay of urinary tryptamine: application as an index of monoamine-oxidase inhibition in man.J. Pharmacol. Exp. Ther.126: 217–222, 1959.
34.
SymthiesJ.R.: Biological Psychiatry.London, Wm. Heinemann Medical Books Ltd., 26–28, 1968.
35.
TanimukaiH.: Modification of paper and thin-layer chromatographic methods to increase sensitivity for detecting N-methylated indoles in urine.J. Chromatogr.30: 155–163, 1967.
36.
TanimukaiH., GintherR., SpaideJ., BuenoJ.R., HimwichH.E.: Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.Br. J. Psychiatry117: 421–430, 1970.
37.
UnderfriendS., TitusE., WeissbachH.: The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.J. Biol. Chem.216: 499–505, 1955.
38.
Von EulerU.S.: Adrenergic neurotransmitter functions.Science173: 202–206, 1971.
39.
WalkerR.W., AhnH.S., Albers-SchönbergG., MandelL.R., Vanden HeuvelW.J.A.: Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma.Biochem. Med.8: 105–113, 1973.
40.
WyattR.J., MandelL.R., AhnH.S., WalkerR.W., Vanden HeuvelW.J.A.: Gas-chromatographic-mass-spectromimetic isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients.Psychopharmacologia31: 265–270, 1973a.
41.
WyattR.J., MurphyD.L., BelmakerR., CohenS., DonnellyC.H., PollinW.: Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.Science179: 916–918, 1973b.
42.
WyattR.J., SaavedraJ.M., AxelrodJ.: A dimethyltryptamine-forming enzyme in human blood.Am. J. Psychistry130: 754–760, 1973c.
43.
WyattR.J., SaavedraJ.M., BelmakerR., CohenS., PollinW.: The dimethyltryptamine-forming enzyme in blood platelets: a study in monozygotic twins discordant for schizophrenia.Am. J. Psychiatry130: 1359–1361, 1973d.